Search

Search articles for

Advanced filters

Published AfterYearMonthDay

Published BeforeYearMonthDay

By Author

By Section

Search Results

##search.searchResults.foundPlural##

Relaxin-2 for heart failure with preserved ejection fraction: a comment on the termination of a phase-II trial investigating the relaxin-2 analogue, LY3540378

Thomas Bernd Dschietzig, Guy Salama

2024-12-30

https://doi.org/10.4081/cardio.2024.56

4833

PDF: 1000

HTML: 122
Lipoprotein(a): what clinicians need to know

Laibah Arshad Khan, Muhammad Hanif, Ahmed Mustafa Rashid

2025-09-01

https://doi.org/10.4081/cardio.2025.80

858

PDF: 1165

HTML: 36
Welcome to Global Cardiology

Andrew J.S. Coats

2023-12-20

https://doi.org/10.4081/cardio.2023.1

2653

pdf: 228

HTML: 4
Global Cardiology issue highlights

Andrew J.S. Coats

2024-06-28

https://doi.org/10.4081/cardio.2024.41

3632

PDF: 477

HTML: 0
The Global Implementation Guidelines Initiative: how to optimize cardio-renal-metabolic care worldwide

Fausto J. Pinto, Stefan D. Anker, William T. Abraham, John J. Atherton, Javed Butler, Vijay Chopra, Andrew J.S. Coats, Yann Colardelle, Maria Rosa Costanzo, Veronica Dean, Gerasimos Filippatos, Martha Gulati, Julio Rosenstock, John Teerlink, Subodh Verma, Jose Luis Zamorano, Yuhui Zhang, Shelley Zieroth

2025-04-16

https://doi.org/10.4081/cardio.2025.68

3939

PDF: 713

Appendix: 474

HTML: 40
Beyond trial neutrality: treatment discontinuation and the hidden signal in SPIRIT-HF trial

Viana Copeland, Andrew J.S. Coats

2026-03-31

https://doi.org/10.4081/cardio.2026.100

1348

PDF: 367

HTML: 183
Glucagon-like peptide-1 receptor agonists and muscle: interpreting lean mass changes in clinical care

Muhammad Sameer Arshad, Maaz Ali, Asad Ali Ahmed Cheema, Stefan D. Anker, Andrew J.S. Coats

2026-03-31

https://doi.org/10.4081/cardio.2026.101

1275

PDF: 478

HTML: 141
Defining iron replete status in patients with heart failure treated with intravenous iron

Khawaja M. Talha, Javed Butler, Stephan von Haehling, Mitja Lainscak, Piotr Ponikowski, Stefan D. Anker

2023-12-21

https://doi.org/10.4081/cardio.2023.17

3354

pdf: 479

HTML: 78
Biological plausibility and implications of obesity associated valvular heart diseases

Francesco Fioretti, Brian R. Lindman, Javed Butler

2024-11-05

https://doi.org/10.4081/cardio.2024.49

2945

PDF: 896

HTML: 36
Evolving targets for heart failure: the journey so far

Giuseppe M.C. Rosano, Jerneja Farkas

2023-11-28

https://doi.org/10.4081/cardio.2023.6

2382

pdf: 445

HTML: 4
To clip or not to clip moderate-to-severe functional mitral regurgitation in patients with heart failure?

Muhammad Shahzeb Khan, Javed Butler, Tim Friede, Piotr Ponikowski, Stefan D. Anker

2024-11-05

https://doi.org/10.4081/cardio.2024.44

3145

PDF: 882

HTML: 39
Large language models to write scientific manuscripts: to be considered but not trusted

Christian Basile, Stefan D. Anker, Gianluigi Savarese

2025-06-30

https://doi.org/10.4081/cardio.2025.74

939

PDF: 344

HTML: 16
Importance of patient-reported outcomes in cardiovascular illnesses

Wardah Rasool, Ahmed Kamal Siddiqi, Laibah Arshad Khan

2025-06-30

https://doi.org/10.4081/cardio.2025.69

2416

PDF: 569

HTML: 178
Treatment pathways in patients with heart failure with preserved ejection fraction and obesity: perspectives from cardiology specialists and patients

Javed Butler, Sanjiv J. Shah, Melissa Magwire, Carlos Campos, Muhammad Shariq Usman, Anthony Hoovler, Anup Sabharwal, Barry A. Borlaug

2024-06-28

https://doi.org/10.4081/cardio.2024.38

2432

PDF: 845

SUPPLEMENTARY MATERIAL: 345

GRAPHICAL ABSTRACT: 297

HTML: 64
Ten-year survival after indirect mitral annuloplasty with the Carillon Mitral Contour System in functional mitral regurgitation. A single-center followup from the REDUCE-FMR trial

Janusz Lipiecki, Piotr Kalmucki, Larry E. Miller, Nicolas Durel

2026-06-26

https://doi.org/10.4081/cardio.2026.106

67

PDF: 16

HTML: 2
Clinical trial design, endpoints and regulatory considerations in heart failure

Giuseppe M.C. Rosano

2024-03-28

https://doi.org/10.4081/cardio.2024.18

5982

PDF: 564

HTML: 69
Advanced cancer as a heart failure like syndrome due to cardiac wasting cardiomyopathy: facts and numbers

Muhammad Shahzeb Khan, Javed Butler, Laibah Arshad Khan, Markus S. Anker

2024-12-30

https://doi.org/10.4081/cardio.2024.58

3626

PDF: 668

HTML: 120

1 - 17 of 17 items

Search

Search Results

Relaxin-2 for heart failure with preserved ejection fraction: a comment on the termination of a phase-II trial investigating the relaxin-2 analogue, LY3540378

Lipoprotein(a): what clinicians need to know

Welcome to Global Cardiology

Global Cardiology issue highlights

The Global Implementation Guidelines Initiative: how to optimize cardio-renal-metabolic care worldwide

Beyond trial neutrality: treatment discontinuation and the hidden signal in SPIRIT-HF trial

Glucagon-like peptide-1 receptor agonists and muscle: interpreting lean mass changes in clinical care

Defining iron replete status in patients with heart failure treated with intravenous iron

Biological plausibility and implications of obesity associated valvular heart diseases

Evolving targets for heart failure: the journey so far

To clip or not to clip moderate-to-severe functional mitral regurgitation in patients with heart failure?

Large language models to write scientific manuscripts: to be considered but not trusted

Importance of patient-reported outcomes in cardiovascular illnesses

Treatment pathways in patients with heart failure with preserved ejection fraction and obesity: perspectives from cardiology specialists and patients

Ten-year survival after indirect mitral annuloplasty with the Carillon Mitral Contour System in functional mitral regurgitation. A single-center followup from the REDUCE-FMR trial

Clinical trial design, endpoints and regulatory considerations in heart failure

Advanced cancer as a heart failure like syndrome due to cardiac wasting cardiomyopathy: facts and numbers

authors

indexing

iCARDIO

Keywords